These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20728447)
1. Induction of growth arrest by miR-542-3p that targets survivin. Yoon S; Choi YC; Lee S; Jeong Y; Yoon J; Baek K FEBS Lett; 2010 Sep; 584(18):4048-52. PubMed ID: 20728447 [TBL] [Abstract][Full Text] [Related]
2. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161 [TBL] [Abstract][Full Text] [Related]
3. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855 [TBL] [Abstract][Full Text] [Related]
4. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152 [TBL] [Abstract][Full Text] [Related]
5. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079 [TBL] [Abstract][Full Text] [Related]
6. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo. Yang W; Sun T; Cao J; Liu F Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Luan S; Sun L; Huang F Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934 [TBL] [Abstract][Full Text] [Related]
8. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells. Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486 [TBL] [Abstract][Full Text] [Related]
9. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Liu B; Peng XC; Zheng XL; Wang J; Qin YW Lung Cancer; 2009 Nov; 66(2):169-75. PubMed ID: 19223090 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801 [TBL] [Abstract][Full Text] [Related]
13. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]
14. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Li KK; Pang JC; Ching AK; Wong CK; Kong X; Wang Y; Zhou L; Chen Z; Ng HK Hum Pathol; 2009 Sep; 40(9):1234-43. PubMed ID: 19427019 [TBL] [Abstract][Full Text] [Related]
15. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Wu Q; Jin H; Yang Z; Luo G; Lu Y; Li K; Ren G; Su T; Pan Y; Feng B; Xue Z; Wang X; Fan D Biochem Biophys Res Commun; 2010 Feb; 392(3):340-5. PubMed ID: 20067763 [TBL] [Abstract][Full Text] [Related]
17. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Visone R; Russo L; Pallante P; De Martino I; Ferraro A; Leone V; Borbone E; Petrocca F; Alder H; Croce CM; Fusco A Endocr Relat Cancer; 2007 Sep; 14(3):791-8. PubMed ID: 17914108 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin. Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Li XF; Yan PJ; Shao ZM Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]